Qiong Wei

Key Laboratory Of Clinical Pharmacology Of Antibiotics, Joint Laboratory Of Hospital & Enterprise For Pathogen Diagnosis Of Drug Resistant Bacterial Infections And Innovative Drug R&D
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Pharmacokinetics, safety and population pharmacokinetics/pharmacodynamics analysis of meropenem-vaborbactam in Chinese healthy participants.

Pharmacokinetics, safety and population pharmacokinetics/pharmacodynamics analysis of meropenem-vaborbactam in Chinese healthy participants.

Journal: Frontiers in pharmacology

Published: May 22, 2026

Safety, Tolerability, and Immunogenicity of a DNA Vaccine (pGX9501) Against SARS-CoV-2 in Healthy Volunteers: A Single-Center, Randomized, Double-Blind, Placebo-Controlled, and Dose-Ranging Phase I Trial.

Safety, Tolerability, and Immunogenicity of a DNA Vaccine (pGX9501) Against SARS-CoV-2 in Healthy Volunteers: A Single-Center, Randomized, Double-Blind, Placebo-Controlled, and Dose-Ranging Phase I Trial.

Journal: Vaccines

Published: April 17, 2025

A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Intranasal Dose of Zavegepant in Healthy Chinese Adults.

A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Intranasal Dose of Zavegepant in Healthy Chinese Adults.

Journal: Clinical pharmacology in drug development

Published: April 17, 2025

Study on drug resistance and molecular typing of food-borne Staphylococcus aureus in Ningxia, 2011-2022

Study on drug resistance and molecular typing of food-borne Staphylococcus aureus in Ningxia, 2011-2022

Journal: Wei sheng yan jiu = Journal of hygiene research

Published: December 24, 2024

Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Cefiderocol in Chinese Healthy Subjects.

Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Cefiderocol in Chinese Healthy Subjects.

Journal: Advances in therapy

Published: November 27, 2024

Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of HLX14 versus reference denosumab in healthy males: A randomized phase I study.

Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of HLX14 versus reference denosumab in healthy males: A randomized phase I study.

Journal: Clinical and translational science

Published: September 27, 2024

Safety, tolerability, and pharmacokinetics of a novel anti-influenza agent ZX-7101A tablets in healthy chinese participants: A first-in-human phase I clinical study.

Safety, tolerability, and pharmacokinetics of a novel anti-influenza agent ZX-7101A tablets in healthy chinese participants: A first-in-human phase I clinical study.

Journal: International journal of antimicrobial agents

Published: August 22, 2024

Lefamulin dosing optimization using population pharmacokinetic and pharmacokinetic/pharmacodynamic assessment in Chinese patients with community-acquired bacterial pneumonia.

Lefamulin dosing optimization using population pharmacokinetic and pharmacokinetic/pharmacodynamic assessment in Chinese patients with community-acquired bacterial pneumonia.

Journal: Frontiers in pharmacology

Published: June 29, 2024

Pharmacokinetics and safety of colistin sulfate after single and multiple intravenous doses in healthy Chinese subjects.

Pharmacokinetics and safety of colistin sulfate after single and multiple intravenous doses in healthy Chinese subjects.

Journal: International journal of antimicrobial agents

Published: March 19, 2024

Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypes.

Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypes.

Journal: Clinical and translational science

Published: February 02, 2024

First-in-human study to evaluate the safety, tolerability, and population pharmacokinetic/pharmacodynamic target attainment analysis of FL058 alone and in combination with meropenem in healthy subjects.

First-in-human study to evaluate the safety, tolerability, and population pharmacokinetic/pharmacodynamic target attainment analysis of FL058 alone and in combination with meropenem in healthy subjects.

Journal: Antimicrobial agents and chemotherapy

Published: December 06, 2023

Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Lefamulin in Healthy Chinese Subjects.

Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Lefamulin in Healthy Chinese Subjects.

Journal: Antibiotics (Basel, Switzerland)

Published: July 24, 2023

Showing 1-12 of 14

Last Updated: 09/26/2026